Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045329 · ClinicalTrials.gov registry record
Impact of Mupirocin Decolonization on the Nasal Microbiome
A clinical trial, sponsored by VA Eastern Colorado Health Care System.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02045329: Clinical Trial study, sponsored by VA Eastern Colorado Health Care System.
NCT02045329 is a clinical trial that was terminated before completion, run by VA Eastern Colorado Health Care System. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02045329 was terminated before completion, sponsored by VA Eastern Colorado Health Care System.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The normal bacteria that inhabit the human nose, also known as the nasal microbiome, may serve as a host defense mechanism against colonization and infection by Staphylococcus aureus, including methicillin resistant S. aureus (MRSA). Mupirocin is a topical antibacterial agent that may be used to clear nasal colonization with S. aureus, and reduce risk of S. aureus infection. The impact of mupirocin on the normal nasal microbiome is not known. We hypothesize that the nasal microbiome is changed by mupirocin. Our study aims to define the nasal microbiome before and after decolonization therapy with mupirocin.
Primary Outcome
This is a descriptive study. We will define the nasal microbiota before and after decolonization therapy with mupirocin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-06-05 |
Why NCT02045329 stopped before completion
NCT02045329 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02045329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02045329 about?
NCT02045329 is a clinical study titled "Impact of Mupirocin Decolonization on the Nasal Microbiome". The normal bacteria that inhabit the human nose, also known as the nasal microbiome, may serve as a host defense mechanism against colonization and infection by Staphylococcus aureus, including methicillin resistant S. aureus (MRSA). Mupirocin is a topical antibacterial agent that may be used to cle...
What is the current status of trial NCT02045329?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2013-10. Estimated completion is 2015-06-05.
Who is sponsoring clinical trial NCT02045329?
This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia